CellCrine
Latest round
- Seed
Last raised
- Sep 2022
Total raised
- Undisclosed
Investors
- 1
About CellCrine
Based in the US, CellCrine Inc. provides defined cell culture conditions for primary cells and cell lines. As of 2022, the company is headed by its CEO Dr. Rodolfo Faudoa. And the company was co-founded by Octavio Gonzalez. The company offers regenerative technology that improves cell growth. Additionally, it provides serum-free media supplements that are designed for each type of cell. The firm’s cell line and strict cell culture conditions enable the production of bio-activated growth-promoting factors.
Who invested in CellCrine
1 investor across 1 round
See all investors in CellCrine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 12, 2022
Amount
Undisclosed
Investors
Questions about CellCrine
Who invested in CellCrine?
CellCrine has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CellCrine raised?
CellCrine has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CellCrine last raise money?
CellCrine's most recent round on record is a Seed, in Sep 2022.
What does CellCrine do?
Based in the US, CellCrine Inc.
Where is CellCrine headquartered?
CellCrine is headquartered in US.
Which VCs invest in companies like CellCrine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CellCrine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like CellCrine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.